Danaher EPS - Earnings per Share 2012-2025 | DHR
Danaher annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Danaher EPS for the quarter ending September 30, 2025 was $1.27, a 13.39% increase year-over-year.
- Danaher EPS for the twelve months ending September 30, 2025 was $4.86, a 7.07% decline year-over-year.
- Danaher 2024 annual EPS was $5.29, a 17.08% decline from 2023.
- Danaher 2023 annual EPS was $6.38, a 33.95% decline from 2022.
- Danaher 2022 annual EPS was $9.66, a 12.2% increase from 2021.
| Danaher Annual EPS | |
|---|---|
| 2024 | $5.29 |
| 2023 | $6.38 |
| 2022 | $9.66 |
| 2021 | $8.61 |
| 2020 | $4.89 |
| 2019 | $4.05 |
| 2018 | $3.74 |
| 2017 | $3.53 |
| 2016 | $3.65 |
| 2015 | $4.74 |
| 2014 | $3.63 |
| 2013 | $3.80 |
| 2012 | $3.36 |
| 2011 | $3.11 |
| Danaher Quarterly EPS | |
|---|---|
| 2025-09-30 | $1.27 |
| 2025-06-30 | $0.77 |
| 2025-03-31 | $1.32 |
| 2024-12-31 | $1.50 |
| 2024-09-30 | $1.12 |
| 2024-06-30 | $1.22 |
| 2024-03-31 | $1.45 |
| 2023-12-31 | $1.44 |
| 2023-09-30 | $1.51 |
| 2023-06-30 | $1.49 |
| 2023-03-31 | $1.94 |
| 2022-12-31 | $3.00 |
| 2022-09-30 | $2.10 |
| 2022-06-30 | $2.25 |
| 2022-03-31 | $2.31 |
| 2021-12-31 | $2.38 |
| 2021-09-30 | $1.54 |
| 2021-06-30 | $2.40 |
| 2021-03-31 | $2.29 |
| 2020-12-31 | $1.68 |
| 2020-09-30 | $1.16 |
| 2020-06-30 | $1.24 |
| 2020-03-31 | $0.81 |
| 2019-12-31 | $1.73 |
| 2019-09-30 | $0.89 |
| 2019-06-30 | $0.97 |
| 2019-03-31 | $0.46 |
| 2018-12-31 | $1.06 |
| 2018-09-30 | $0.93 |
| 2018-06-30 | $0.95 |
| 2018-03-31 | $0.80 |
| 2017-12-31 | $1.21 |
| 2017-09-30 | $0.81 |
| 2017-06-30 | $0.79 |
| 2017-03-31 | $0.72 |
| 2016-12-31 | $1.06 |
| 2016-09-30 | $0.56 |
| 2016-06-30 | $0.94 |
| 2016-03-31 | $1.09 |
| 2015-12-31 | $0.97 |
| 2015-09-30 | $2.01 |
| 2015-06-30 | $0.97 |
| 2015-03-31 | $0.79 |
| 2014-12-31 | $0.92 |
| 2014-09-30 | $0.95 |
| 2014-06-30 | $0.95 |
| 2014-03-31 | $0.81 |
| 2013-12-31 | $1.11 |
| 2013-09-30 | $0.84 |
| 2013-06-30 | $0.87 |
| 2013-03-31 | $0.98 |
| 2012-12-31 | $0.89 |
| 2012-09-30 | $0.77 |
| 2012-06-30 | $0.84 |
| 2012-03-31 | $0.86 |
| 2011-12-31 | $0.80 |
| 2011-09-30 | $0.74 |
| 2011-06-30 | $0.94 |
| 2011-03-31 | $0.63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $166.691B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.839B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.83 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |